This activity is supported by an educational grant from Merck & Co., Inc.
The promise of immunotherapy in oncology has become a reality with the US Food and Drug Administration (FDA) approval… More »
September 30, 2015
The development of new treatments for patients with advanced melanoma in the past decade has been… More »
This activity is supported by an educational grant from Genentech, Inc and Merck & Co., Inc.
Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for… More »